全文获取类型
收费全文 | 1248篇 |
免费 | 48篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 39篇 |
妇产科学 | 18篇 |
基础医学 | 108篇 |
口腔科学 | 36篇 |
临床医学 | 80篇 |
内科学 | 386篇 |
皮肤病学 | 6篇 |
神经病学 | 101篇 |
特种医学 | 49篇 |
外科学 | 217篇 |
综合类 | 5篇 |
一般理论 | 6篇 |
预防医学 | 53篇 |
眼科学 | 24篇 |
药学 | 57篇 |
中国医学 | 1篇 |
肿瘤学 | 111篇 |
出版年
2023年 | 9篇 |
2022年 | 8篇 |
2021年 | 23篇 |
2020年 | 16篇 |
2019年 | 24篇 |
2018年 | 22篇 |
2017年 | 14篇 |
2016年 | 19篇 |
2015年 | 23篇 |
2014年 | 42篇 |
2013年 | 64篇 |
2012年 | 97篇 |
2011年 | 115篇 |
2010年 | 61篇 |
2009年 | 63篇 |
2008年 | 103篇 |
2007年 | 118篇 |
2006年 | 112篇 |
2005年 | 100篇 |
2004年 | 84篇 |
2003年 | 64篇 |
2002年 | 57篇 |
2001年 | 10篇 |
2000年 | 1篇 |
1999年 | 6篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1996年 | 7篇 |
1995年 | 7篇 |
1994年 | 2篇 |
1993年 | 6篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1983年 | 1篇 |
1980年 | 1篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1966年 | 1篇 |
1956年 | 1篇 |
排序方式: 共有1309条查询结果,搜索用时 0 毫秒
991.
Fountas KN Kapsalaki EZ Feltes CH Smisson HF Johnston KW Robinson JS 《Neurocritical care》2004,1(2):195-199
Introduction: Accurate knowledge of cerebral temperature is assuming increasing importance, because its manipulation is employed more frequently
for cerebral protection.
Purpose: This prospective clinical study was performed to examine how well intraventricular temperature reflects global cerebral temperature. 相似文献
992.
993.
Kolibianakis EM Zikopoulos K Smitz J Camus M Tournaye H Van Steirteghem AC Devroey P 《Fertility and sterility》2004,82(1):223-226
After administration of GnRH antagonist from day 1 of stimulation for IVF, 12.1 cumulus oocyte complexes were retrieved (95% confidence interval [CI], 10.6-13.6), 1.9 embryos were transferred (95% CI, 1.7-2.0), and 2.4 embryos were cryopreserved (95% CI, 1.7-3.1). Stimulation for 8.8 days (95% CI, 8.4-9.2) with recombinant FSH resulted in an ongoing implantation rate of 26.5% (95% CI, 17.1-35.9) and an ongoing pregnancy rate of 39.7% per started cycle (95% CI, 30.1-50.8) and of 42.4% per ET (95% CI, 32.3-53.1). 相似文献
994.
995.
Bairaktari ET Tzallas C Kalientzidou M Tselepis AD Siamopoulos KC Seferiadis KI Elisaf MS 《Clinical biochemistry》2004,37(10):937-940
OBJECTIVES: To evaluate alternative equations for the estimation of low-density lipoprotein cholesterol (LDL-C) than the Friedewald equation in hemodialysis patients. DESIGN AND METHODS: The equations LDL-C = 0.41TC - 0.14TG + 0.66ApoB - 10.43 and LDL-C = 0.94TC - 0.94HDL-C - 0.19TG were evaluated in 86 patients and compared with the Friedewald equation and the ultracentrifugation procedure. RESULTS: The alternative equations yield significantly lower bias than the Friedewald equation and are less affected by increased triglycerides (TG) levels. CONCLUSION: The alternative equations for LDL-C yield slightly better results than the Friedewald equation especially in hypertriglyceridemia. 相似文献
996.
Kakolyris S Ziras N Vamvakas L Varthalitis J Papakotoulas P Syrigos K Vardakis N Kalykaki A Amarantidis K Georgoulias V 《Lung cancer (Amsterdam, Netherlands)》2006,54(3):347-352
PURPOSE: To evaluate the activity and tolerance of gemcitabine in combination with oxaliplatin (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: Thirty-two patients with advanced NSCLC who had disease progression after a cisplatin- and taxane-based front-line regimen were treated with gemcitabine (1500 mg/m(2) on days 1 and 8) and oxaliplatin (130 mg/m(2) on day 8) every 3 weeks. The patients' median age was 62 years and the performance status (WHO) was 0 for 11, 1 for 17 and 2 for 4 patients. The treatment was second line for 22 (69%) and >or=third line for 10 (31%) patients. RESULTS: Partial response was achieved in 5 (16%) patients, stable disease in 8 (25%) and progressive disease in 19 (59%). Two patients with stable disease and one patient with progressive disease while on previous chemotherapy experienced a partial response with GEMOX regimen. The median duration of response was 2.5 months (range, 1-11.5), the median time to tumor progression 3 months (range, 1-18) and the median survival 5.6 months (range, 1-31). Grade III neutropenia occurred in five (16%) patients, grade III thrombocytopenia in two (6%) and grade III anemia in three (9%); moreover, grades II-III asthenia was reported in eight (25%) patients and grades II-III neurotoxicity in three (9%). CONCLUSION: The GEMOX combination is a relatively active and well tolerated second-line regimen in NSCLC patients pretreated with a taxane- and/or platinum-based chemotherapy. 相似文献
997.
Androulakis N Aravantinos G Syrigos K Polyzos A Ziras N Tselepatiotis E Samonis G Kentepozidis N Giassas S Vamvakas L Georgoulias V 《Oncology》2006,70(4):280-284
BACKGROUND: A multicenter phase II study was conducted in order to evaluate the efficacy and safety of oxaliplatin as first-line treatment of patients with locally advanced or metastatic carcinoma of the biliary tract. PATIENTS AND METHODS: Twenty-nine chemo-na?ve patients with locally advanced or metastatic biliary tract carcinoma received oxaliplatin 130 mg/m(2) i.v. every 21 days. Patients were treated until tumor progression or unacceptable toxicity. RESULTS: An objective response (3 complete responses, 3 partial responses) was achieved in 6 patients (20.6%, 95% CI 5.95-35.4). Disease control (complete response, partial response and stable disease) was observed in 14 patients (48.2%). The median time to tumor progression was 3 months (range 0.7-39) and the median overall survival was 7 months (range 1-39). The 1-year survival rate was 32%. Toxicity was mild. CONCLUSION: Oxaliplatin is an active agent against biliary tract carcinoma and therefore should be further investigated in combination with other cytotoxic drugs. 相似文献
998.
Ardavanis A Mavroudis D Kalbakis K Malamos N Syrigos K Vamvakas L Kotsakis A Kentepozidis N Kouroussis C Agelaki S Georgoulias V;Breast Cancer Committee of the Hellenic Oncology Research Group 《Cancer chemotherapy and pharmacology》2006,58(6):742-748
Purpose: To investigate the activity and tolerance of pegylated liposomal doxorubicin in combination with vinorelbine in pretreated patients with metastatic breast cancer. Patients and treatment: Thirty-six women with metastatic breast cancer were enrolled. The median age was 64 years, 80% of the patients had a performance status of 0–1, 30 (83%) had visceral disease and 83% had received prior taxanes while 50% anthracyclines. Treatment consisted of pegylated liposomal doxorubicin (40 mg/m2 on day 1) and vinorelbine (25 mg/m2 on days 1 and 15) every 4 weeks. Results: In an intention-to-treat analysis 2 (6%) complete and 12 (33%) partial responses were observed (overall response rate 39%; 95% CI: 23–54.8%); 8 (22%) and 14 (39%) patients experienced stable and progressive disease, respectively. The median TTP was 6.5 months and the median survival time 14.2 months. The 1-year survival rate was 54.1%. Grade 3 and 4 neutropenia occurred in 21 (58%) patients, grade 3–4 anemia in four (11%) and grade 4 thrombocytopenia in one (3%). Two (6%) patients developed febrile neutropenia. Non-hematologic toxicity was mild and easily manageable. There was no clinically important cardiac toxicity or treatment-related deaths. Conclusions: The combination of pegylated liposomal doxorubicin and vinorelbine is an active and well tolerated salvage regimen in patients with metastatic breast cancer which merits further evaluation. 相似文献
999.
1000.
Demosthenes B. Panagiotakos Anastasios Papadimitriou Michael B. Anthracopoulos Maria Konstantinidou George Antonogeorgos rew Fretzayas Kostas N. Priftis 《Pediatrics international》2008,50(4):563-568
Background: The purpose of the present study was to determine the prevalence of overweight and obesity in a sample of Greek children aged 10–12 years, and to evaluate these rates in relation to parental weight and birthweight.
Methods: During the 2005–2006 school period, 700 schoolchildren (323 boys, 377 girls) were randomly recruited from 18 schools, in Athens. Height and weight were measured and body mass index (BMI) was calculated. Cut-off points for BMI defining obesity and overweight for gender and age were calculated in accordance with international standards.
Results: Overall, 8.6% of boys and 9.0% of girls were obese, and 33.9% of boys and 22.1% of girls were overweight. Having an obese parent increased the odds of having an overweight or obese child (P < 0.01). Compared to non-breast-fed, boys who were breast-fed for >3 months had 70% lower likelihood of being overweight or obese (P < 0.01) and breast-fed girls had 80% lower odds (P < 0.01). Excessive birthweight (>3500 g) increased by 2.5-fold the likelihood of being overweight or obese only in girls (P < 0.05).
Conclusions: Parental weight, lack of breast-feeding and excess birthweight (in girls) were significant predictors of overweight or obesity in Greek children aged 10–12 years. 相似文献
Methods: During the 2005–2006 school period, 700 schoolchildren (323 boys, 377 girls) were randomly recruited from 18 schools, in Athens. Height and weight were measured and body mass index (BMI) was calculated. Cut-off points for BMI defining obesity and overweight for gender and age were calculated in accordance with international standards.
Results: Overall, 8.6% of boys and 9.0% of girls were obese, and 33.9% of boys and 22.1% of girls were overweight. Having an obese parent increased the odds of having an overweight or obese child (P < 0.01). Compared to non-breast-fed, boys who were breast-fed for >3 months had 70% lower likelihood of being overweight or obese (P < 0.01) and breast-fed girls had 80% lower odds (P < 0.01). Excessive birthweight (>3500 g) increased by 2.5-fold the likelihood of being overweight or obese only in girls (P < 0.05).
Conclusions: Parental weight, lack of breast-feeding and excess birthweight (in girls) were significant predictors of overweight or obesity in Greek children aged 10–12 years. 相似文献